Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells

Clinical and Experimental Immunology

Volumn 114, Issue 1, 1998, Pages 113-118

  Moosig, F ^b   Csernok, E ^a   Wang, G ^b   Gross, W L ^b  

^a Rheumaklinik Bad Bramstedt   (Germany)

^b NONE

Author keywords

B7; CD28; Costimulatory molecules; Wegener's granulomatosis

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; METHOTREXATE; PREDNISONE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES; UP-REGULATION; WEGENER GRANULOMATOSIS;

EID: 0031718132     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00695.x     Document Type: Article

References (26)

1. Csernok E, Müller A, Wang G, Trabandt A, Paulsen J, Schnabel A, Gross WL. Cytokine profiles in Wegener's granulomatosis: predominance of type-1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1998, in press.
2. Schlesier M, Kaspar T. Gutfleisch J, Wolff-Vorbeck G, Peter HH. Activated CD4+ and CD8+ T cell subsets in Wegener's granulomatosis. Rheumatol Int 1995; 14:213-9.
3. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Arthritis Rheum 1992; 35:1088-96.
4. Wang G, Hansen H, Tatsis E, Csernok E, Gross WL. High plasma levels of soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis. Am J Med 1997; 102:517-23.
5. Martens PB, Goronzy JJ, Schaid D, Weyand WM. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum 1997; 40:1106-14.
6. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996; 97:2027-37.
7. Tsokos GC, Kovacs B, Sfikakis PP, Theocharis S, Vogelgesang S, Via CS. Defective antigen-presenting cells function in patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39:600-9.
8. Nakajima A, Azuma M, Kodera S et al. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Eur J Immunol 1995; 25:3060-9.
9. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
10. Jenette CJ, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitis: proposal of an international consensus conference. Arthritis Rheum 1994; 37:187-92.
11. Reinhold-Keller E, Kekow J, Schnabel A, Schmitt WH, Heller M, Beigel A, Duncker G, Gross WL. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. Arthritis Rheum 1994; 37:919-24.
12. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection. II Functional defects of CD28-T cells. AIDS 1994; 8:431-41.
13. Fagnoni FF, Vscovini R, Mazzola M et al. Expansion of cytotoxic CD8+ CD28-T cells in healthy ageing people, including centenarians. Immunology 1996; 88:501-7.
14. Park W, Weyand CM, Schmidt D, Goronzy JJ. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28-T cells. Eur J Immunol 1997; 27:1082-90.
15. Rulifson CR, Sperlin AI, Fields PE, Fitch FW, Bluestone JA. CD28 costimulation promotes the production of Th2 cytokines. J Immunol 1997; 158:658-65.
16. Webb LMC, Feldmann M. Critical role of CD28/B7 costimulation in the development of human Th2 cytokine-producing cells. Blood 1995; 86:3479-86.
17. King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G. CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 1995; 25:587-95.
18. Caruso A, Licenziati S, Canaris AD et al. Characterization of T cell subsets involved in the production of IFN-gamma in asymptomatic HIV-infected patients. AIDS Res Hum Retrovirus 1996; 12:135-41.
19. Choremi-Papadopoulou H, Viglis V, Gargalianos P, Kordossis A, Iniotaki-Theodoraki A, Kosmidis J. Downregulation of CD28 surface antigen on CD4+ and CD8+ T lymphocytes during HIV-1 infection. J Acquir Immune Defic Syndr 1994; 7:245-53.
20. Brinchmann JE, Dohloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in HIV infection: functional and clinical correlations. J Infect Dis 1994; 169:730-8.
21. Wolthers KC, Otto SA, Lens SMA, Kolbach DN, van Lier RAW, Miedema F, Meyaard L. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ cells. Eur J Immunol 1996; 26:1700-6.
22. Ikeda M, Tsuru S, Watanabe Y, Kitahara Inouye T. Reduced CD4/CD8 T cell ratios in patients with Wegener's granulomatosis. J Clin Lab Immunol 1992; 38:103-9.
23. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application in autoimmune disease therapy. Cell 1995; 80:707-18.
24. Petro TM, Chen SS, Panther RB. Effect of CD80 and CD86 on T cell cytokine production. Immunol Invest 1995; 24:965-76.
25. Gause WM, Halvorson MJ, Lu P, Greenwald R, Linsley P, Urban JF, Finkelmann FD. The function of costimulatory molecules and the development of IL-4 producing T cells. Immunol Today 1997; 18:115-20.
26. Azuma M, Yssel H, Philips JH, Spits H, Lanier LL. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993; 177:845-50.